Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $523 thousand versus the consensus estimate of $510 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.